DTIL PRECISION BIOSCIENCES INC

NEUTRAL Impact: 3/10 8-K
Horizon months Filed Jun 16, 2026 Processed 4d 11h ago SEC 0001628280-26-043526
8-K material event: Items 1.01
Latest settled — T+1d
DTIL ▲ +4.77% at T+1d
NEUTRAL call ✓ call won +4.77% · α vs SPY +3.99% · entry $6.50 → $6.81
Next anchor: T+5d in 3d
Last close $6.81 (close Jun 18) · +4.77% from $6.50 entry
Entry anchored
Jun 16, 03:59 PM ET
via Databento tick
T+1d
+4.77%
call +4.77% · α +3.99%
$6.81
settled 4d ago
T+5d
call — · α —
in 3d
T+20d
call — · α —
in 24d
T+60d
call — · α —
in 3mo

Price Chart

Loading chart...

Executive Summary

Precision BioSciences amended its existing loan agreement with Banc of California, extending the Term Loan maturity date from June 30, 2027 to December 31, 2029. No new borrowing, changes to principal, interest rate, or other terms were disclosed. The extension provides additional runway for the company's operations and pipeline development.

Actionable Insight

The maturity extension reduces near-term refinancing risk for Precision BioSciences, but does not provide new capital. Monitor for future financing needs or pipeline catalysts that could affect the company's ability to service debt.

Key Facts

  • Term Loan maturity extended by 2.5 years, from June 30, 2027 to December 31, 2029
  • No changes to principal amount, interest rate, or other material terms disclosed
  • Amendment executed with Banc of California, the existing lender

Financial Impact

No dollar amounts disclosed; the amendment extends the maturity of an existing term loan without altering principal or interest terms.

debt_maturity

Risk Factors

  • Company still requires additional capital to fund operations beyond the extended maturity date
  • No new cash infusion; existing cash burn rate unchanged

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
90% bullish (10 analysts)

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001628280-26-043526
Document: a1011stamendmenttoarlsa.htm0001628280-26-043526
Document: 0001628280-26-043526-index-headers.html0001628280-26-043526
Document: 0001628280-26-043526-index.html0001628280-26-043526
Document: 0001628280-26-043526.txt0001628280-26-043526
6 reports for DTIL
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for DTIL — sortable, filterable
Type Now
Jun 16, 2026
4d ago
8-K
NEUTRAL ★ 3/10
$6.50 $6.81▲ +4.77%▲ +3.99%$6.81 (+4.77%)
May 27, 2026
24d ago
8-K
BULLISH ★ 7/10
$7.59 $6.92▼ −8.83%▼ −9.38%$6.81 (−10.28%)
May 26, 2026
25d ago
8-K
NEUTRAL ★ 4/10
$7.59 $6.92▼ −8.83%▼ −9.38%$6.81 (−10.28%)
May 5, 2026
6w ago
8-K
NEUTRAL ★ 4/10
$7.45 $7.52▲ +0.94%▼ −0.45%$6.81 (−8.59%)
Apr 8, 2026
10w ago
DEFA14A
NEUTRAL ★ 3/10
$5.99 $6.61▲ +10.35%▲ +9.78%$6.81 (+13.69%)
Mar 12, 2026
14w ago
8-K
NEUTRAL ★ 4/10
$5.67 $5.67· 0.00%▲ +0.60%$6.81 (+20.11%)
Showing 6 of 6

US Market Status

Market Closed — Opens Mon (29h 32m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access